Home Amersham Biosciences

Amersham Biosciences

Out of service
-
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Amersham Biosciences, a life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a global leader in the development and provision of integrated systems and solutions for disease research, drug discovery, and biopharmaceutical manufacturing. Its systems are used to elucidate the functions of genes and proteins for drug discovery and development as well as for the manufacturing of biopharmaceuticals.
Amersham Biosciences Corp.
United Kingdom
more than 500 people
January 01, 1997
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs